XENE | Pipeline Review | Centroid 7.0 Rank 1 | XGB/GRU ReviewXenon Pharmaceuticals Inc.NASDAQ:XENEQuant_Signal_Engine**Pipeline Output** Ticker: XENE Company: XENON PHARMACEUTICALS INC Date reviewed: 2026-06-26 Centroid: 7 Centroid rank: 1 Sector: Health Care Close: 59.74 Volume: 8,839,702 **Why this is on my review list** XENE appeared in my pipeline as a current long execution. This is not a manual chart pick. It is a review of what the pipeline produced. **Model Read** XGB p_up: 91.79% GRU p_up: 87.69% Both classification models were aligned to the upside regime on this row. The regression side was XGB ROR +0.03%, GRU ROR -0.60%. **Risk Reference** Close: 59.74 Initial stop/reference level: 56.61 The stop area gives a defined risk reference for reviewing how the trade behaves after the signal. **Follow-up Plan** I’ll review this ticker in future updates as either an active open trade, a failed review candidate, or a completed trade outcome. **Source / Purpose** This stock-result review is part of my daily machine-learning pipeline journal. The ticker was selected from a model-generated scan using price, trend, trade-state, centroid grouping, and XGB/GRU probability outputs. The purpose is to document what the pipeline produced and then follow up on what happened afterward. Quant Signal Engine @QuantSignalEngine This is a research journal and educational review, not financial advice or a recommendation to buy or sell.